
About GT+R 2023
Join leading biopharmaceutical and biotechnology executives, patient advocacy groups, community-based lived experience rare disease professionals, government and regulatory authorities, investors and seasoned solution providers in discussing current trends, evolutionary innovations, best practices, strategic business models, real-world solutions, market access and so much more within the gene therapy and rare disease ecosystems.
GT+R 2023 is a novel event, curating seasoned experts from across the gene therapy and rare disease therapeutic research and development industries. This conference is a must attend event for thought leaders, advocates, researchers and industry executives trailblazing novel solution-driven pathways for the future of gene therapy and rare disease innovation.
Join GT+R 2023 for four (4) days in Boston from June 26 - 29, 2023 for the most comprehensive program and inclusive gathering of rare disease stakeholders to date.
Patient Advocacy Travel Scholarships
GT+R is offering Patient Advocacy Travel Scholarships to encourage the engagement of patient advocates and community-based activists from the gene therapy and rare diseases communities by providing financial support for their attendance. These awards are provided to offset the cost of registration, travel and/or accommodations associated with attending the conference.
You may apply for a scholarship by clicking on the button below. Note that all available scholarships are contingent on available funds from the ‘Patient Advocacy Travel Fund’ sponsorship. GT+R organizers reserve the right to reject any applications. Only complete applications will be eligible for consideration.
GT+R Executive Planning Committee

MICHELL BUTLER
Sr. Director of Clinical Services,
Curant Health

NADIA BODKIN
Founder, Rare Advocacy Movement (RAM)
.jpg)
MICHAEL FOSSEL
President and Founder
Telocyte

RAJESH B. SHUKLA
Senior Medical Director
SSI Strategy
GT+R Speakers

SIMI AHMED
Senior VP, Strategic Partnerships, New York Stem Cell Foundation

ANGELA COLUMBANO
Head Business Development and Partnership, Genethon

COLIN DINNEY
Department Chairman, Department of Urology, UT MD Anderson Cancer Center

DANIELLE DRAYTON
CEO and Founder, REACH Market Research

MARK DELVAUX
President and CEO, AlphaNet, Inc.

JEFF GILMORE
Chief Executive Officer, cGMPNow

MIN GUAN
Senior Staff Scientist, T Cell Therapeutics Research Laboratory, City of Hope National Medical Center

ASAEL HERMAN
Chief Operating Officer, Emendo Biotherapeutics

PAUL HERMONAT
Chief Executive Officer, Houston Gene Therapeutics

DANIEL KAVANAGH
Senior Scientific Advisor, Gene Therapy, WCG
.jpg)
SHANE HEGARTY
Chief Scientific Officer & Co-Founder, AXONIS Therapeutics
.jpg)
BOSE KALAMPANAYIL
CTO, Neurophth Therapeutics
For Sponsor Opportunities and General Inquiry Contact

Rashmi Jain
Email: rashmi.jain@biogatescientificcenter.com
Phone: +91 8886276665
Why Attend GT+R 2023
The time is now for action. Attendees will have the opportunity to:
-
Engage with vetted thought-leaders and seasoned industry, advocacy, academic and community-based stakeholders
-
Participate in strategically designed networking sessions and breaks
-
Identify and explore professional development opportunities
-
Identify and discuss novel, sustainable solutions to therapeutic development pain points & issues
-
Learn about innovative collaborations that are on the frontier and foster new ones
-
Participate at the first of its kind gene therapy and rare disease conference designed by a collaboration of seasoned industry experts
RESERVE YOUR SPOT TODAY

VENUE
The Westin Waltham
70 3rd Ave, Waltham, MA 02451, United States
A limited number of rooms have been blocked for GT+R attendees at the Westin, Waltham. You may confirm your lodging accommodation at the discounted rate of $300.00 USD per night upon purchasing your conference ticket(s).
Due to limited availability, lodging accommodations will be treated on a “first come first serve” basis.
For any inquiries regarding accommodation, please contact: rashmi.jainbiogatescientificcenter.com
Attendee Snapshot GT+R 2023
Executive decision-makers in the fields of gene therapy and rare diseases are the majority of attendees registered for GT+R 2023. The following is a list of stakeholders in which we expect the largest participation on a global scale:
-
Academia
-
Pharmaceutical/Biotechnology
-
Patient Advocacy & Community
-
Clinical Development
-
Recruitment & Retention
-
Commercial & Media Services
-
Digital Health Diagnostics
-
Genetic Counseling
-
Investors
-
Medical Affairs
-
Regulatory Affairs
-
Precision Medicine
-
Pre-Clinical/Non-Clinical
-
Specialty Pharmacy
-
Transitionary Care
-
Intellectual Property
-
Market Research & Global Access
SPONSORS & EXHIBITORS
SHOWCASE YOUR BRAND TO EXPERTS IN THE FIELD OF GENE THERAPY & RARE DISEASES
GT+R 2023 is an expert crafted event in which industry, academic, advocacy and community-based professionals will network, connect and learn from each other.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product, brand and/or services, rather than just a name on an exhibition list.